As of 2025-07-05, the Relative Valuation of Avanos Medical Inc (AVNS) is (210.85) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.35 USD, the upside of Avanos Medical Inc based on Relative Valuation is -1807.3%.
The range of the Relative Valuation is (182.15) - (247.03) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.9x - 35.2x | 28.6x |
| Forward P/E multiples | 14.6x - 29.7x | 22.2x |
| Fair Price | (182.15) - (247.03) | (210.85) |
| Upside | -1574.9% - -2100.2% | -1807.3% |
| Date | P/E |
| 2025-07-03 | -1.48 |
| 2025-07-02 | -1.49 |
| 2025-07-01 | -1.51 |
| 2025-06-30 | -1.47 |
| 2025-06-27 | -1.47 |
| 2025-06-26 | -1.46 |
| 2025-06-25 | -1.48 |
| 2025-06-24 | -1.49 |
| 2025-06-23 | -1.46 |
| 2025-06-20 | -1.46 |
| 2025-06-18 | -1.45 |
| 2025-06-17 | -1.46 |
| 2025-06-16 | -1.47 |
| 2025-06-13 | -1.45 |
| 2025-06-12 | -1.49 |
| 2025-06-11 | -1.48 |
| 2025-06-10 | -1.55 |
| 2025-06-09 | -1.52 |
| 2025-06-06 | -1.50 |
| 2025-06-05 | -1.48 |
| 2025-06-04 | -1.50 |
| 2025-06-03 | -1.50 |
| 2025-06-02 | -1.45 |
| 2025-05-30 | -1.51 |
| 2025-05-29 | -1.52 |
| 2025-05-28 | -1.49 |
| 2025-05-27 | -1.54 |
| 2025-05-23 | -1.48 |
| 2025-05-22 | -1.50 |
| 2025-05-21 | -1.53 |
| 2025-05-20 | -1.57 |
| 2025-05-19 | -1.56 |
| 2025-05-16 | -1.58 |
| 2025-05-15 | -1.53 |
| 2025-05-14 | -1.46 |
| 2025-05-13 | -1.53 |
| 2025-05-12 | -1.57 |
| 2025-05-09 | -1.52 |
| 2025-05-08 | -1.51 |
| 2025-05-07 | -1.51 |
| 2025-05-06 | -1.54 |
| 2025-05-05 | -1.47 |
| 2025-05-02 | -1.48 |
| 2025-05-01 | -1.48 |
| 2025-04-30 | -1.51 |
| 2025-04-29 | -1.53 |
| 2025-04-28 | -1.53 |
| 2025-04-25 | -1.48 |
| 2025-04-24 | -1.51 |
| 2025-04-23 | -1.49 |